Cargando…

Correction: Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965552/ http://dx.doi.org/10.1371/journal.pone.0093778

Ejemplares similares

Methylation of BRCA1 Promoter Region Is Associated with Unfavorable Prognosis in Women with Early-Stage Breast Cancer
por: Hsu, Nicholas C., et al.
Publicado: (2013)

Correction to Expression of Concern on: Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma
Publicado: (2020)

Identifying patients with an unfavorable prognosis in early stages of colorectal carcinoma
por: Hendricks, Alexander, et al.
Publicado: (2018)

Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ikejima, Kengo, et al.
Publicado: (2023)

The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer
por: Sharma, Priyanka, et al.
Publicado: (2014)

Correction: Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
por: Stefansson, Olafur Andri, et al.
Publicado: (2009)

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer
por: Lokk, Kaie, et al.
Publicado: (2017)

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
por: Gaudet, Mia M., et al.
Publicado: (2010)

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
por: Gaudet, Mia M., et al.
Publicado: (2010)

Correction: CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients
Publicado: (2015)

Correction to ‘DNA methylation subpatterns at distinct regulatory regions in human early embryos’
por: Luo, Rongsong, et al.
Publicado: (2018)

Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial
por: Yamauchi, Hideko, et al.
Publicado: (2023)

BRCA1 Expression Status in Relation to DNA Methylation of the BRCA1 Promoter Region in Sporadic Breast Cancers
por: Niwa, Youko, et al.
Publicado: (2000)

Correction to: Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
por: de Sabando, Ainara Ruiz, et al.
Publicado: (2019)

Author Correction: Multiple gene promoter methylation and clinical stage in adjacent normal tissues: Effect on prognosis of colorectal cancer in Taiwan
por: Hsu, Chih-Hsiung, et al.
Publicado: (2020)

Correction: Increased neutrophil-to-lymphocyte ratio is associated with unfavorable functional outcomes in acute pontine infarction
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Correction: Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020)

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: De Talhouet, Solene, et al.
Publicado: (2020)

Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
por: Jank, Paul, et al.
Publicado: (2021)

Correction to: Mastectomy with one-stage or two-stage reconstruction in breast cancer: analysis of early outcomes and patient’s satisfaction
por: Gurrado, Angela, et al.
Publicado: (2022)

Methylation of BRCA1 promoter in sporadic breast cancer
por: Jagtap, Sunil Vitthalrao, et al.
Publicado: (2023)

Correction to: Plasma Total Homocysteine Level Is Related to Unfavorable Outcomes in Ischemic Stroke With Atrial Fibrillation
Publicado: (2022)

Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
por: Buchanan, Adam H., et al.
Publicado: (2021)

Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU
por: Dhillon, Sohita
Publicado: (2019)

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
por: Vos, Shoko, et al.
Publicado: (2017)

BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer
por: Otani, Yoko, et al.
Publicado: (2014)

Correction: Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
por: Lee, Ning Yuan, et al.
Publicado: (2022)

Correction to: Association of invasion-promoting tenascin-C additional domains with breast cancers in young women
por: Guttery, David S., et al.
Publicado: (2018)

Correction to: Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
por: Yao, Bing, et al.
Publicado: (2022)

Correction to: Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review
por: Huber, D., et al.
Publicado: (2021)

Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2021)

Correction: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2018)

Correction: The Trouble with Sliding Windows and the Selective Pressure in BRCA1
por: Schmid, Karl, et al.
Publicado: (2008)

Correction: Molecular profile of BRCA-mutated biliary tract cancers
Publicado: (2020)

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
por: Coignard, Juliette, et al.
Publicado: (2021)

Correction: Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection
por: Schummer, Michèl, et al.
Publicado: (2010)

CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma
por: Ma, Chao, et al.
Publicado: (2019)

Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers
por: Walker, Logan C., et al.
Publicado: (2018)

Author Correction: Physical activity and sleep behaviour in women carrying BRCA1/2 mutations
por: Galasso, Letizia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eccf2cbjlo2glqvql9ha7b6shi